Hearn Jay Cho
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma (NCT02655458) | Hearn Jay Cho | 2016-01-01 |
Track Hearn Jay Cho automatically
Every clearance here is in the API, with alerts when new ones post.